Stent: Interventions
Interventions
Changes that would cut emissions or material use, by lever and life stage, with effect per unit, readiness, adoption, evidence and who acts
| Lever | Life stage | Change | Effect per unit | Readiness | Adoption | Who acts | Source |
|---|---|---|---|---|---|---|---|
| Design | Components design | Thinner struts in cobalt-chromium and platinum-chromium stents | Struts of 50 to 90 µm against 130 to 150 µm in stainless steel stents [2]; a lower metal mass is likely but no source gives a stent mass | Deployed | New-generation drug-eluting stents have the thinner struts [2] | Stent makers | [2] |
| Substitute | Components design | Dissolving scaffolds in place of permanent metal | No permanent metal is left, but the Absorb's struts were 150 µm against 81 µm for the Xience [6], and its development was reported to have failed to achieve further clinical benefits [5] | Piloted and set back (CE mark January 2011, FDA approval July 2016 [7]) | Not given in any source opened | Stent makers, regulators | [6][5][7] |
| Substitute | Use | Pathway footprint: a study of one Australian hospital cohort found the whole stenting pathway had a lower footprint than the bypass surgery pathway | 2.4 tonnes CO2e per stenting procedure, against 11.5 tonnes for bypass surgery, in 29 stenting patients at one Sydney hospital; a per-procedure figure for the whole pathway, not per stent, and not a basis for choosing a treatment, which rests on clinical need [18] | Deployed (both procedures in routine use) | Not given in any source opened | Clinicians and hospitals | [18] |
as of 2026-11-13
Sources
- State of the art: coronary artery stents – past, present and future EuroIntervention (Stefanini, Byrne, Windecker and Kastrati), 2017, EuroIntervention 2017;13:706-716
- Modern Stents: Where Are We Going? Rambam Maimonides Medical Journal (Kobo and others), 2020, RMMJ 2020;11(2):e0017, DOI 10.5041/RMMJ.10403
- Inception of the coronary stent: a story of successful collaboration between innovative scientists and the biotechnology industry REC: Interventional Cardiology 6(4):321-331 (Macaya-Ten, Gonzalo, Escaned, Macaya), 2024
- The Surprising History Behind an Extremely Common Cardiovascular Medical Device MD+DI, no byline or date shown on the page
- Healthcare-related carbon footprinting—lower impact of a coronary stenting compared to a coronary surgery pathway Frontiers in Public Health, volume 12 (Sack and others), 2024, published 21 August 2024; Royal Prince Alfred Hospital, Sydney; 29 stenting patients, 2021 to 2022